Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTATP6P2 (mitochondrially encoded ATP synthase 6 pseudogene 2) is a nuclear-encoded pseudogene related to the mitochondrial MT-ATP6 gene, which itself encodes an essential subunit of the mitochondrial ATP synthase complex responsible for ATP production in oxidative phosphorylation[1][3]. As a pseudogene, MTATP6P2 does not encode a functional protein and has no characterized biological activity, molecular functions, disease associations, or drug interactions. There is no data supporting its role as a drug target, biomarker, or its involvement in human disease. Searches for MTATP6P2 typically yield entries for functional MT-ATP6, but these should not be conflated, as MTATP6P2 is a non-functional relic and not a therapeutic target. If you require information about the actual mitochondrial ATP synthase 6 (MT-ATP6), please specify, as that is a distinct, functionally important mitochondrial gene and established disease gene[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on mitochondrially encoded ATP synthase 6 pseudogene 2 (MTATP6P2).